NxStage Medical, Inc. (NXTM) Shares Sold by New York State Common Retirement Fund

New York State Common Retirement Fund lessened its holdings in shares of NxStage Medical, Inc. (NASDAQ:NXTM) by 14.3% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 63,600 shares of the medical device company’s stock after selling 10,600 shares during the quarter. New York State Common Retirement Fund owned approximately 0.10% of NxStage Medical worth $1,820,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of NXTM. Quantamental Technologies LLC acquired a new stake in shares of NxStage Medical during the 4th quarter worth $110,000. Tower Research Capital LLC TRC acquired a new stake in shares of NxStage Medical during the 3rd quarter worth $136,000. Rehmann Capital Advisory Group increased its holdings in shares of NxStage Medical by 2,689.0% during the 3rd quarter. Rehmann Capital Advisory Group now owns 5,578 shares of the medical device company’s stock worth $200,000 after buying an additional 5,378 shares during the last quarter. Tokio Marine Asset Management Co. Ltd. acquired a new stake in shares of NxStage Medical during the 4th quarter worth $215,000. Finally, Janus Henderson Group PLC increased its holdings in shares of NxStage Medical by 25.5% during the 3rd quarter. Janus Henderson Group PLC now owns 10,505 shares of the medical device company’s stock worth $293,000 after buying an additional 2,134 shares during the last quarter. 80.34% of the stock is currently owned by institutional investors.

A number of research firms have recently commented on NXTM. BidaskClub upgraded NxStage Medical from a “strong sell” rating to a “sell” rating in a report on Friday, February 22nd. Zacks Investment Research upgraded NxStage Medical from a “hold” rating to a “buy” rating and set a $33.00 price objective for the company in a report on Tuesday, February 5th.

NASDAQ NXTM remained flat at $$30.00 during trading hours on Monday. The company had a trading volume of 2,608,346 shares, compared to its average volume of 1,506,712. NxStage Medical, Inc. has a 52-week low of $23.17 and a 52-week high of $30.00. The firm has a market cap of $2.00 billion, a P/E ratio of -136.36 and a beta of 0.25.

ILLEGAL ACTIVITY WARNING: “NxStage Medical, Inc. (NXTM) Shares Sold by New York State Common Retirement Fund” was first published by Baseball Daily News and is the property of of Baseball Daily News. If you are accessing this story on another website, it was illegally copied and reposted in violation of United States and international copyright law. The original version of this story can be viewed at https://www.baseballdailydigest.com/news/2019/04/15/nxstage-medical-inc-nxtm-shares-sold-by-new-york-state-common-retirement-fund.html.

NxStage Medical Profile

NxStage Medical, Inc, a medical technology company, develops, manufactures, and markets products and services for patients suffering from chronic or acute kidney failure. Its primary product includes the System One, a portable hemodialysis system, which is used primarily for home hemodialysis and a range of dialysis therapies to deliver in the home setting.

Read More: What is required to own or exchange cryptocurrency?

Institutional Ownership by Quarter for NxStage Medical (NASDAQ:NXTM)

Receive News & Ratings for NxStage Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NxStage Medical and related companies with MarketBeat.com's FREE daily email newsletter.